Authors: Tonge, R Shaw, J Middleton, B Rowlinson, R Rayner, S Young, J Pognan, F Hawkins, E Currie, I Davison, M

Citation: R. Tonge et al., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology, PROTEOMICS, 1(3), 2001, pp. 377-396

Authors: Macdonald, N Chevalier, S Tonge, R Davison, N Rowlinson, R Young, J Rayner, S Roberts, R

Citation: N. Macdonald et al., Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP), ARCH TOXIC, 75(7), 2001, pp. 415-424

Authors: Chevalier, S Macdonald, N Tonge, R Rayner, S Rowlinson, R Shaw, J Young, J Davison, M Roberts, RA

Citation: S. Chevalier et al., Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumour necrosis factor alpha or the peroxisome proliferator nafenopin, EUR J BIOCH, 267(15), 2000, pp. 4624-4634

Authors: Macdonald, N Barrow, K Tonge, R Davison, M Roberts, RA Chevalier, S

Citation: N. Macdonald et al., PPAR alpha-dependent alteration of GRP94 expression in mouse hepatocytes, BIOC BIOP R, 277(3), 2000, pp. 699-704

Authors: Chen, WQ Shockcor, JP Tonge, R Hunter, A Gartner, C Nelson, SD

Citation: Wq. Chen et al., Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel Ipso adduct, BIOCHEM, 38(25), 1999, pp. 8159-8166

Authors: Tonge, R Larsen, PC Ito, M

Citation: R. Tonge et al., Strategic leadership in super-growth companies - A re-appraisal, LONG RANG P, 31(6), 1998, pp. 838-847